PDI Healthcare, a global leader in infection prevention products and solutions, is testing several of its disinfectant products for efficacy against SARS-CoV-2, the virus that causes COVID-19, for submission to the Environmental Protection Agency for approval.

Partnering with Microbac Laboratories for testing, PDI hospital-grade products could be among the products with demonstrated effectiveness against the novel coronavirus.

Infection prevention experts have been looking to the EPA’s Emerging Viral Pathogens Program for guidance on what products may work as disinfectants, based on knowledge of similar pathogens. The program is intended to bridge the gap when outbreaks occur, giving laboratories time to acquire the novel virus for product testing.

For instance, Texas-based R-Water is assisting on the front lines with an EPA-regulated device that produces its own healthcare-grade disinfectant. The Texas Department of Aging and Disability Services confirmed efficacy with a 60-second contact time, allowing the water-hypochlorous acid mix to be used in facilities.

Earlier this month, Decon7 Systems’ D7 — a patented, EPA registered disinfectant, food contact surface sanitizer, deodorizer and chemical cleaner — received its official EPA designation for killing the novel coronavirus.

D7 had previously demonstrated effectiveness against viruses similar to COVID-19 on hard, non-porous surfaces. Therefore, D7 can be used against COVID-19 when used in accordance with the directions.

More EPA approvals could help providers better understand what works against the coronavirus, where to find solutions and exactly how to use them.

“The world is dealing with a virus we have never seen before, and we know surfaces play a critical role in spreading the infection,” said Sean Gallimore, general manager and senior vice president for PDI. “As the leader in providing infection prevention solutions to healthcare institutions, we are committed to advancing the science and understanding of SARS-CoV-2. The goal of our research partnership with Microbac is to bring confidence that our products can be used to disinfect surfaces in hospitals and other sites of care, ultimately protecting caregivers, patients and communities.”

Sani Professional, PDI’s food safety division focused on prevention of community associated infection, is also testing the following products:

Until official announcements are made, disinfectants found on the EPA’s List N should continue to be used according to their label instructions.